跳至主要内容
临床试验/CTRI/2019/04/018830
CTRI/2019/04/018830尚未招募1/2 期

A standard controlled clinical study of Guduchyadi Anjana and Olopatadine(0.2%)eye drops in the management of simple allergic conjunctivitis.

PDEAs college of ayurveda and research centre1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2019年6月5日最近更新:

试验速览

阶段
1/2 期
状态
尚未招募
发起方
入组人数
52
试验地点
1
主要终点
To study the efficacy of Guduchyadi anjana and olopatadine0.2% eye drops in simple allergic conjunctivitis

研究概览

简要总结

Simple allergic conjunctivitis is the most common form of occular allergy. It is caused due to seasonal allergens like grass, pollens, weeds, contact with animals, certain flowers and pollution. In modern medicine, allergic conjunctivitis is treated with steroids and H1 receptor antagonists which can be harmful. Allergic conjunctivitis can be curable by medicinal procedure like anjana with help of medicinal formulation of guguchi.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • known case of simple allergic conjunctivitis.

排除标准

  • 1.known case of congenital anomalies of eye 2.known case of any other known occular pathology,conjunctivitis with corneal involvement 3.known case of bacterial conjunctivitis,viral conjunctivitis and any other occular infections 4.one eye patient.

结局指标

主要结局

To study the efficacy of Guduchyadi anjana and olopatadine0.2% eye drops in simple allergic conjunctivitis

时间窗: 7 days with follow up on 7th,147th,21st and 28th day

次要结局

  • To observe the adverse effects if any(28 days)

研究者

发起方
PDEAs college of ayurveda and research centre
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验